DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Flovent Rotadisk (Fluticasone Propionate Inhalation) - Published Studies


Published Studies Related to Flovent Rotadisk (Fluticasone Inhalation)

Well-designed clinical trials related to Flovent Rotadisk (Fluticasone Inhalation)

Fluticasone impact on airway dendritic cells in smokers: a randomized controlled trial. [2013]

Long-term monotherapy with suplatast tosilate in patients with mild atopic asthma: a pilot comparison with low-dose inhaled fluticasone. [2011.06]

Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. [2011.05]

Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers. [2011.04]

Difference between patient-reported side effects of ciclesonide versus fluticasone propionate. [2010.12]

Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma. [2010.12]

Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. [2010.11.15]

The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients. [2010.10]

Montelukast added to fluticasone propionate does not alter inflammation or outcomes. [2010.10]

Inhaled fluticasone propionate reduces postoperative sore throat, cough, and hoarseness. [2010.10]

Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. [2010.10]

Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer. [2010.06]

Effect of fluticasone on markers of inflammation and quality of life in steroid-naive patients with mild asthma. [2010.01]

Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. [2010.01]

Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. [2010]

Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. [2010]

Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. [2010]

Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study. [2009.12]

Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children. [2009.12]

Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED). [2009.11]

The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. [2009.10.31]

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. [2009.10.20]

Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. [2009.10]

Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma. [2009.10]

A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination. [2009.08]

Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. [2009.08]

Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. [2009.05]

Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. [2009.04]

Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. [2009.04]

Effect of inhaled fluticasone on lung function in infants with recurrent wheezing: a randomised controlled trial. [2009.03]

In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler. [2009.02]

Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. [2009.01.22]

Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related. [2008.11]

Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics. [2008.11]

[Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.] [2008.11]

Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. [2008.08]

Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler. [2008.07]

Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients. [2008.07]

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. [2008.06.01]

Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]

Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma. [2008.06]

Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD. [2008.06]

Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers. [2008.06]

Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate. [2008.05.22]

Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]

Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents. [2008.05]

Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial. [2008.04]

Efficacy and safety of fluticasone propionate/salmeterol 250/50mcg Diskus administered once daily. [2008.04]

Efficacy of fluticasone metered-dose inhaler and dry powder inhaler for pediatric asthma. [2008.02]

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. [2008.01.01]

Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma. [2008.01]

Endocrine and immunologic effects of inhaled fluticasone propionate in healthy dogs. [2008.01]

Salmeterol/Fluticasone Propionate via Diskustrade mark Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids. [2008]

Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study. [2008]

The Efficacy and Safety of Combination Salmeterol (50 {micro}g)/Fluticasone Propionate (500 {micro}g) Inhalation Twice Daily Via Accuhaler in Chinese Patients With COPD. [2007.12]

Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. [2007.12]

Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures. [2007.11]

Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. [2007.11]

Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. [2007.10]

Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients. [2007.09]

Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]

A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma. [2007.08]

Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]

Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma. [2007.07]

[A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between hfa-bdp and fluticasone propionate] [2007.06]

The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium. [2007.05.15]

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. [2007.04.17]

Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. [2007.04]

Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma. [2007.04]

Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler). [2007.03]

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. [2007.02.22]

Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma. [2007]

Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma. [2007]

Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients. [2007]

Lung bioavailability of hydrofluoroalkane fluticasone in young children when delivered by an antistatic chamber/mask. [2006.12]

Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study. [2006.11]

A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. [2006.10]

Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthma. [2006.09]

Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. [2006.08.26]

High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. [2006.08]

Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data. [2006.07]

Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate. [2006.07]

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. [2006.06]

Comparison of three valved holding chambers for the delivery of fluticasone propionate-HFA to an infant face model. [2006.06]

Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses. [2006.06]

Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. [2006.05]

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. [2006.04.01]

Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. [2006.03]

Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978]. [2006.02.06]

Non-viral wheezing in preschool children: the effect of inhaled fluticasone on symptoms and lung function. [2006.02]

Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids. [2006.01]

Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. [2006.01]

Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. [2006]

Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. [2006]

Minimal tolerance to the bronchoprotective effect of inhaled salmeterol/fluticasone combination on allergene challenge. [2006]

Fluticasone Propionate HFA-134a Pressurized Metered-Dose Inhaler in Adolescents and Adults with Moderate to Severe Asthma. [2005.12]

Co-administration of salbutamol and fluticasone for emergency treatment of children with moderate acute asthma. [2005.11]

The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms. [2005.11]

Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. [2005.10]

Once-daily administration of fluticasone propionate does not worsen controlled airway hyperresponsiveness in patients with asthma. [2005.09]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017